Disorder-associated mutations lead to functional inactivation of neuroligins

Human Molecular Genetics

Volumn 13, Issue 14, 2004, Pages 1471-1477

  Chih, Ben ^a   Afridi, Shehla Khan ^a   Clark, Lorraine ^a   Scheiffele, Peter ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CELL ADHESION MOLECULE; MUTANT PROTEIN; NEUROLIGIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTISM; BEHAVIOR DISORDER; BRAIN NERVE CELL; COGNITIVE DEFECT; CONTROLLED STUDY; GENE FUNCTION; GENE INACTIVATION; GENE OVEREXPRESSION; HIPPOCAMPUS; MENTAL DEFICIENCY; MENTAL PATIENT; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVE ENDING; NONHUMAN; NONSENSE MUTATION; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; ARGININE; ASPARTIC ACID; AUTISTIC DISORDER; CARRIER PROTEINS; CERCOPITHECUS AETHIOPS; COS CELLS; GENETIC PREDISPOSITION TO DISEASE; HIPPOCAMPUS; HUMANS; MEMBRANE PROTEINS; MENTAL RETARDATION; MUTATION, MISSENSE; NERVE TISSUE PROTEINS; NEURONS; POINT MUTATION; PROTEIN TRANSPORT;

EID: 3543136466     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddh158     Document Type: Article

References (39)

1. Lord, C., Cook, E.H., Leventhal, B.L. and Amaral, D.G. (2000) Autism spectrum disorders. Neuron, 28, 355-363.
2. Volkmar, F.R. and Pauls, D. (2003) Autism. Lancet, 362, 1133-1141.
3. Keller, F. and Persico, A.M. (2003) The neurobiological context of autism. Mol. Neurobiol., 28, 1-22.
4. Bailey, A., Le Couteur, A., Gottesman, L, Bolton, P., Simonoff, E., Yuzda, E. and Rutter, M. (1995) Autism as a strongly genetic disorder: evidence from a British twin study. Psychol. Med., 25, 63-77.
5. Folstein, S. and Rutter, M. (1977) Infantile autism: a genetic study of 21 twin pairs. J. Child. Psychol. Psychiatry, 18, 297-321.
6. Folstein, S.E. and Rosen-Sheidley, B. (2001) Genetics of autism: complex aetiology for a heterogeneous disorder. Nat. Rev. Genet., 2, 943-955.
7. Zoghbi, H.Y. (2003) Postnatal neurodevelopmental disorders: meeting at the synapse? Science, 302, 826-830.
8. Huttenlocher, P.R. and Dabholkar, A.S. (1997) Regional differences in synaptogenesis in human cerebral cortex. J. Comp. Neurol., 387, 167-178.
9. Raymond, G.V., Bauman, M.L. and Kemper, T.L. (1996) Hippocampus in autism: a Golgi analysis. Acta Neuropathol. (Berl.), 91, 117-119.
10. Armstrong, D.D., Dunn, K. and Antalffy, B. (1998) Decreased dendritic branching in frontal, motor and limbic cortex in Rett syndrome compared with trisomy 21. J. Neuropathol. Exp. Neurol., 57, 1013-1017.
11. Armstrong, D., Dunn, J.K., Antalffy, B. and Trivedi, R. (1995) Selective dendritic alterations in the cortex of Rett syndrome. J. Neuropathol. Exp. Neurol., 54, 195-201.
12. Philippe, A., Martinez, M., Guilloud-Bataille, M., Gillberg, C., Rastam, M., Sponheim, E., Coleman, M., Zappella, M., Aschauer, H., Van Maldergem, L. et al. (1999) Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study. Hum. Mol. Genet., 8, 805-812.
13. Thomas, N.S., Sharp, A.J., Browne, C.E., Skuse, D., Hardie, C. and Dennis, N.R. (1999) Xp deletions associated with autism in three females. Hum. Genet., 104, 43-48.
14. Shao, Y., Wolpert, C.M., Raiford, K.L., Menold, M.M., Donnelly, S.L., Ravan, S.A., Bass, M.P., McClain, C., von Wendt, L., Vance, J.M. et al. (2002) Genomic screen and follow-up analysis for autistic disorder. Am. J. Med. Genet., 114, 99-105.
15. Auranen, M., Vanhala, R., Varilo, T., Ayers, K., Kempas, E., Ylisaukko-Oja, T., Sinsheimer, J.S., Peltonen, L. and Jarvela, I. (2002) A genomewide screen for autism-spectrum disorders: evidence for a major susceptibility locus on chromosome 3q25-27. Am. J. Hum. Genet., 71, 777-790.
16. Jamain, S., Quach, H., Betancur, C., Rastam, M., Colineaux, C., Gillberg, I.C., Soderstrom, H., Giros, B., Leboyer, M., Gillberg, C. et al. (2003) Mutations of X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet., 34, 27-29.
17. Ichtchenko, K., Hata, Y., Nguyen, T., Ullrich, B., Missler, M., Moomaw, C. and Südhof, T.C. (1995) Neuroligin 1: a splice site-specific ligand for beta-neurexins. Cell, 81, 435-443.
18. Song, J.Y., Ichtchenko, K., Südhof, T.C. and Brose, N. (1999) Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses. Proc. Natl Acad. Sci. USA, 96, 1100-1105.
19. Scheiffele, P., Fan, J., Choih, J., Fetter, R. and Serafini, T. (2000) Neuroligin expressed in nonneuronal cells triggers presynaptic developmut in contacting axons. Cell, 101, 657-669.
20. Dean, C., Scholl, F.G., Choih, J., DeMaria, S., Berger, J., Isacoff, E. and Scheiffele, P. (2003) Neurexin mediates the assembly ofpresynaptic terminals. Nat. Neurosci., 6, 708-716.
21. Ichtchenko, K., Nguyen, T. and Südhof, T.C. (1996) Structures, alternative splicing, and neurexin binding of multiple neuroligins. J. Biol. Chem., 271, 2676-2682.
22. Irie, M., Hata, Y., Takeuchi, M., Ichtchenko, K., Toyoda, A., Hirao, K., Takai, Y., Rosahl, T.W. and Südhof, T.C. (1997) Binding of neuroligins to PSD-95. Science, 277, 1511-1515.
23. Bolliger, M.F., Frei, K., Winterhalter, K.H. and Gloor, S.M. (2001) Identification of a novel neuroligin in humans which binds to PSD-95 and has widespread expression. Biochem. J., 356, 581-588.
24. Nguyen, T. and Südhof, T.C. (1997) Binding properties of neuroligin 1 and neurexin 1beta reveal function as heterophilic cell adhesion molecules. J. Biol. Chem., 272, 26032-26039.
25. Hoffman, R.C., Jennings, L.L., Tsigelny, L, Comoletti, D., Flynn, R.E., Südhof, T.C. and Taylor, P. (2004) Structural characterization of recombinant soluble rat neuroligin 1: mapping of secondary structure and glycosylation by mass spectrometry. Biochemistry, 43, 1496-1506.
26. Scholl, F.G. and Scheiffele, P. (2003) Making connections: cholinesterase-domain proteins in the CNS. Trends Neurosci., 26, 618-624.
27. Trombetta, E.S. and Parodi, A.J. (2003) Quality control and protein folding in the secretory pathway. Annu. Rev. Cell Dev. Biol., 19, 649-676.
28. Laumonnier, F., Bonnet-Brilhault, F., Gomot, M., Blanc, R., David, A., Moizard, M.P., Raynaud, M., Ronce, N., Lemonnier, E., Calvas, P. et al. (2004) X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am. J. Hum. Genet., 74, 552-557.
29. Sussman, J.L., Harel, M., Frolow, F., Oefner, C., Goldman, A., Toker, L. and Silman, I. (1991) Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science, 253, 872-879.
30. Bourne, Y., Taylor, P., Bougis, P.E. and Marchot, P. (1999) Crystal structure of mouse acetylcholinesterase. A peripheral site-occluding loop in a tetrameric assembly. J. Biol. Chem., 274, 2963-2970.
31. Maquat, L.E. (2004) Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nat. Rev. Mol. Cell Biol., 5, 89-99.
32. Sitia, R., Neuberger, M., Alberini, C., Bet, P., Fra, A., Valetti, C., Williams, G. and Milstein, C. (1990) Developmental regulation of IgM secretion: the role of the carboxy-terminal cysteine. Cell, 60, 781-790.
33. Bottomley, M.J., Batten, MR., Lumb, R.A. and Bulleid, N.J. (2001) Quality control in the endoplasmic reticulum: PDI mediates the ER retention of unassembled procollagen C-propeptides. Curr. Biol., 11, 1114-1118.
34. Denning, G.M., Anderson, M.P., Amara, J.F., Marshall, J., Smith, A.E. and Welsh, M.J. (1992) Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature, 358, 761-764.
35. Foster, B.A., Coffey, H.A., Morin, M.J. and Rastinejad, F. (1999) Pharmacological rescue of mutant p53 conformation and function. Science, 286, 2507-2510.
36. Fan, J.Q., Ishii, S., Asano, N. and Suzuki, Y. (1999) Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor. Nat. Med., 5, 112-115.
37. Morello, J.P., Salahpour, A., Laperriere, A., Bernier, V., Arthus, M.F., Lonergan, M., Petaja-Repo, U., Angers, S., Morin, D., Bichet, D.G. et al. (2000) Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J. Clin. Invest., 105, 887-895.
38. Wiens, G.D., O'Hare, T. and Rittenberg, M.B. (2001) Recovering antibody secretion using a hapten ligand as a chemical chaperone. J. Biol. Chem., 276, 40933-40939.
39. Dean, C. and Scheiffele, P. (2004) Imaging synaptogenesis by measuring accumulation of synaptic proteins in transfected primary neurons. In Yuste, R. and Konnerth, A. (eds), Imaging in Neuroscience and Development. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, in press.